Findings from this study support use of serial MRD monitoring during lenalidomide maintenance therapy to identify patients likely to benefit from prolonged treatment.
This study separately evaluated the impact of depression/antidepressant use on the QOL and OS of cohorts of patients undergoing allogeneic or autologous HSCT.
Higher graft CD34+ cell content is linked to improved platelet and neutrophil recovery after high-dose therapy.
Involvement of nurses trained in the management of selinexor-associated AEs in patients with multiple myeloma is a key element of these recommendations.
IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.